世界のオメプラゾール市場見通し2027

【英語タイトル】Global Omeprazole Market Outlook 2027

Research Nesterが出版した調査資料(NEST20JN032)・商品コード:NEST20JN032
・発行会社(調査会社):Research Nester
・発行日:2020年5月
・ページ数:104
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,150 ⇒換算¥444,050見積依頼/購入/質問フォーム
Site License(同一拠点閲覧用)USD5,150 ⇒換算¥551,050見積依頼/購入/質問フォーム
Enterprisewide License(同一法人閲覧用)USD7,150 ⇒換算¥765,050見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Global Omeprazole Market Analysis – 2018-2027Omeprazole is usually prescribed as proton pump inhibitor (PPI), which helps to reduce acidity. It is mainly used for the treatment of heartburn as well as for the symptoms related to gastroesophageal reflux disease. Omeprazole is also widely used as a combination drug with antibiotics like amoxicillin and clarithromycin for the treatment of ulcers caused by H. pylori bacteria. The global omeprazole market is anticipated to achieve a CAGR of around 6% during the forecast period, i.e. 2019-2027. Factors such as growing prevalence of acid refluxes, respiratory disorders, heart-related issues and others amongst the growing number of elderly populations, increasing opportunities generated from the increasing focus on innovation and development for low-cost generics by the pharmaceutical manufacturers and rising number of obese people globally are anticipated to contribute towards the growth of the global omeprazole market. Additionally, factors such as increasing awareness for the treatment of several gastrointestinal disorders amongst individuals, coupled with the rising number of patients who are suffering from peptic ulcers are some of the factors anticipated to drive the growth of the global omeprazole market.
The global omeprazole market consists of various segments that are segmented by dosage form, distribution channel, indication and by region. The distribution channel segment is further sub-divided into hospital, retail and online. Out of these, the hospital segment, which had a market value of around USD 900 million in the year 2018 is anticipated to hold the largest market share by the end of 2027 and cross a value of around USD 1500 million by growing at a CAGR of around 6.5% over the forecast period.
Based on region, the global omeprazole market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in Asia Pacific, which had a value of around USD 420 million in the year 2018 is anticipated to grow at a moderate pace over the forecast period and cross a value of around USD 770 million by the end of 2027.
Some of the affluent industry leaders in the global omeprazole market are Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Sandoz International GmbH, Mylan N.V., Apotex, Inc., Amneal Pharmaceuticals LLC, Perrigo Company plc, Salix Pharmaceuticals and Allergan plc.

【レポートの目次】

Global Omeprazole Market
1. Report Overview
1.1. Global Omeprazole Market Overview
1.2. Why You Should Read This Report
1.3. How This Report Delivers
1.4. Key Questions Answered by This Analytical Report
1.5. Who is This Report For?
1.6. Methodology
1.6.1. Primary Research
1.6.2. Secondary Research
1.6.3. Market Evaluation & Forecasting Methodology
2. Introduction to the Omeprazole Market
2.1. Omeprazole Market Structure
2.2. Omeprazole Market Definition
2.3. Global Omeprazole Market Taxonomy
2.4. Global Omeprazole Market Snapshot
2.5. Global Omeprazole Market Dynamics
2.5.1. Global Omeprazole Market: Driver
2.5.2. Global Omeprazole Market: Restraints
2.5.1. Global Omeprazole Market: Trends
2.5.1. Global Omeprazole Market: Opportunities
3. Global Omeprazole Market, By Dosage Form, 2019-2027
3.1. Introduction
3.2. Global Omeprazole Market Size and Forecast, By Dosage Form
3.2.1. Capsule Segment
3.2.2. Tablet Segment
3.2.3. Powder Segment
4. Global Omeprazole Market, By Distribution Channel, 2019-2027
4.1. Introduction
4.2. Global Omeprazole Market Size and Forecast, By Distribution Channel
4.2.1. Hospital Pharmacies Segment
4.2.2. Retail Pharmacies Segment
4.2.3. Online Pharmacies Segment
5. Global Omeprazole Market, By Indication, 2019-2027
5.1. Introduction
5.2. Global Omeprazole Market Size and Forecast, By Indication
5.2.1. Duodenal Ulcer Segment
5.2.2. Gastric Ulcer Segment
5.2.3. Gastroesophageal Reflux Disease Segment
5.2.4. Erosive Esophagitis Segment
5.2.5. Others Segment
6. Global Omeprazole Market, By Region, 2019-2027
6.1. Introduction
6.2. Global Omeprazole Market Size and Forecast, By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East and Africa
7. North America Omeprazole Market Analysis and Forecast, 2019-2027
7.1. Introduction
7.1.1. North America
7.2. North America Omeprazole Market Forecast, By Country, 2019-2027
7.3. North America Omeprazole Market Forecast, By Dosage Form, 2019-2027
7.4. North America Omeprazole Market Forecast, By Distribution Channel, 2019-2027
7.5. North America Omeprazole Market Forecast, By Indication, 2019-2027
8. Latin America Omeprazole Market Analysis and Forecast, 2019-2027
8.1. Introduction
8.1.1. Latin America
8.2. Latin America Omeprazole Market Forecast, By Country, 2019-2027
8.1. Latin America Omeprazole Market Forecast, By Dosage Form, 2019-2027
8.2. Latin America Omeprazole Market Forecast, By Distribution Channel, 2019-2027
8.3. Latin America Omeprazole Market Forecast, By Indication, 2019-2027
9. Europe Omeprazole Market Analysis and Forecast, 2019-2027
9.1. Introduction
9.1.1. Europe
9.2. Europe Omeprazole Market Forecast, By Country, 2019-2027
9.3. Europe Omeprazole Market Forecast, By Dosage Form, 2019-2027
9.4. Europe Omeprazole Market Forecast, By Distribution Channel, 2019-2027
9.5. Europe Omeprazole Market Forecast, By Indication, 2019-2027
10. Asia Pacific Omeprazole Market Analysis and Forecast, 2019-2027
10.1. Introduction
10.1.1. Asia Pacific
10.2. Asia Pacific Omeprazole Market Forecast, By Country, 2019-2027
10.3. Asia Pacific Omeprazole Market Forecast, By Dosage Form, 2019-2027
10.4. Asia Pacific Omeprazole Market Forecast, By Distribution Channel, 2019-2027
10.5. Asia Pacific Omeprazole Market Forecast, By Indication, 2019-2027
11. Middle East & Africa Omeprazole Market Analysis and Forecast, 2019-2027
11.1. Introduction
11.1.1. MEA
11.2. MEA Omeprazole Market Forecast, By Country, 2019-2027
11.3. MEA Omeprazole Market Forecast, By Dosage Form, 2019-2027
11.4. MEA Omeprazole Market Forecast, By Distribution Channel, 2019-2027
11.5. MEA Omeprazole Market Forecast, By Indication, 2019-2027
12. Company Profiles
12.1. ASTRAZENECA PLC
12.1.1. Overview
12.1.2. Product Type/Service Offerings
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.2. SANDOZ INTERNATIONAL GMBH
12.2.1. Overview
12.2.2. Product Type/Service Offerings
12.2.3. Key Developments: NA
12.2.4. SWOT Analysis
12.3. MYLAN N.V.
12.3.1. Overview
12.3.2. Product Type/Service Offerings
12.3.3. Key Developments: NA
12.3.4. SWOT Analysis
12.4. APOTEX, INC
12.4.1. Overview
12.4.2. Product Type/Service Offerings
12.4.3. Key Developments: NA
12.4.4. SWOT Analysis
12.5. DR. REDDY’S LABORATORIES INC
12.5.1. Overview
12.5.2. Product Type/Service Offerings
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.6. IMPAX LABORATORIES, INC
12.6.1. Overview
12.6.2. Product Type/Service Offerings
12.6.3. Key Developments: NA
12.6.4. SWOT Analysis
12.7. PERRIGO COMPANY PLC
12.7.1. Overview
12.7.2. Product Type/Service Offerings
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.8. SALIX PHARMACEUTICALS, INC
12.8.1. Overview
12.8.2. Product Type/Service Offerings
12.8.3. Key Developments: NA
12.8.4. SWOT Analysis
12.9. ALLERGAN PLC
12.9.1. Overview
12.9.2. Product Type/Service Offerings
12.9.3. Key Developments: NA
12.9.4. SWOT Analysis
13. Acronyms



★調査レポート[世界のオメプラゾール市場見通し2027] (コード:NEST20JN032)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のオメプラゾール市場見通し2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆